KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Capital Employed (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 15 years of Return on Capital Employed data on record, last reported at 0.2% in Q3 2025.

  • For Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.2%; the TTM value through Sep 2025 reached 0.2%, changed N/A, while the annual FY2024 figure was 0.01%, 24.0% down from the prior year.
  • Return on Capital Employed reached 0.2% in Q3 2025 per VRTX's latest filing, down from 0.2% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.3% in Q1 2021 and bottomed at 0.04% in Q1 2025.
  • Average Return on Capital Employed over 5 years is 0.21%, with a median of 0.22% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: fell -4bps in 2021, then dropped -25bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.26% in 2021, then decreased by -2bps to 0.25% in 2022, then fell by -18bps to 0.21% in 2023, then increased by 5bps to 0.21% in 2024, then fell by -7bps to 0.2% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.2% in Q3 2025, 0.2% in Q2 2025, and 0.04% in Q1 2025.